MarketScreener Editorial Features Canntab Therapeutics Limited Deutsche Boerse AG
Equities
TBF1
CA1377991023
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0005 EUR | -.--% | -.--% | -.--% |
04-15 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
2023 | Canntab Therapeutics Limited Provide an Update on Product Delivery | CI |
- Stock Market
- Equities
- PILL Stock
- TBF1 Stock
- News Canntab Therapeutics Limited
- MarketScreener Editorial Features